Vaccine-resistant disease threatens children; GeoVax presents results;

> Streptococcus pneumoniae, a disease that most often strikes children under five and the elderly, is becoming a growing threat to children as it becomes resistant to an otherwise effective vaccine. Article

> Atlanta-based GeoVax Labs presented data on their AIDS vaccine (trial HVTN 065) at the AIDS Vaccine 2008 conference. GeoVax is preparing to launch Phase II trials of the drug. Release

> Austrailia's Ian Frazer has won the Prime Minister's Prize for Science for is work on the Gardasil vaccine. Article

And Finally... A new polio vaccine could help wipe out the disease in Nigeria, one of the few places in the world where polio is not yet eliminated. Report

Suggested Articles

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.